nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—DRD2—Gilles de la Tourette syndrome	0.8	1	CbGaD
Fenoldopam—DRD5—nervous system—Gilles de la Tourette syndrome	0.00182	0.0613	CbGeAlD
Fenoldopam—DRD5—central nervous system—Gilles de la Tourette syndrome	0.00175	0.059	CbGeAlD
Fenoldopam—DRD1—midbrain—Gilles de la Tourette syndrome	0.00169	0.057	CbGeAlD
Fenoldopam—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00149	0.0503	CbGeAlD
Fenoldopam—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00146	0.0492	CbGeAlD
Fenoldopam—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00144	0.0484	CbGeAlD
Fenoldopam—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00141	0.0473	CbGeAlD
Fenoldopam—DRD5—brain—Gilles de la Tourette syndrome	0.00139	0.0469	CbGeAlD
Fenoldopam—DRD1—nervous system—Gilles de la Tourette syndrome	0.00139	0.0468	CbGeAlD
Fenoldopam—DRD1—central nervous system—Gilles de la Tourette syndrome	0.00134	0.0451	CbGeAlD
Fenoldopam—ADRA1B—brain—Gilles de la Tourette syndrome	0.00114	0.0384	CbGeAlD
Fenoldopam—ADRA1D—brain—Gilles de la Tourette syndrome	0.00112	0.0376	CbGeAlD
Fenoldopam—DRD1—brain—Gilles de la Tourette syndrome	0.00106	0.0358	CbGeAlD
Fenoldopam—DRD2—midbrain—Gilles de la Tourette syndrome	0.001	0.0337	CbGeAlD
Fenoldopam—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000973	0.0327	CbGeAlD
Fenoldopam—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000839	0.0282	CbGeAlD
Fenoldopam—DRD2—nervous system—Gilles de la Tourette syndrome	0.000823	0.0277	CbGeAlD
Fenoldopam—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000808	0.0272	CbGeAlD
Fenoldopam—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.0008	0.0269	CbGeAlD
Fenoldopam—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000792	0.0266	CbGeAlD
Fenoldopam—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000776	0.0261	CbGeAlD
Fenoldopam—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.00077	0.0259	CbGeAlD
Fenoldopam—ADRA2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000698	0.0041	CbGpPWpGaD
Fenoldopam—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000696	0.00408	CbGpPWpGaD
Fenoldopam—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000687	0.00403	CbGpPWpGaD
Fenoldopam—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00068	0.00399	CbGpPWpGaD
Fenoldopam—ADRA1A—brain—Gilles de la Tourette syndrome	0.000641	0.0216	CbGeAlD
Fenoldopam—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000638	0.0215	CbGeAlD
Fenoldopam—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000633	0.00372	CbGpPWpGaD
Fenoldopam—DRD2—brain—Gilles de la Tourette syndrome	0.000629	0.0212	CbGeAlD
Fenoldopam—ADRA2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000628	0.00369	CbGpPWpGaD
Fenoldopam—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000614	0.0207	CbGeAlD
Fenoldopam—ADRA2C—brain—Gilles de la Tourette syndrome	0.000611	0.0206	CbGeAlD
Fenoldopam—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00061	0.00358	CbGpPWpGaD
Fenoldopam—ADRA2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000587	0.00344	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00058	0.00341	CbGpPWpGaD
Fenoldopam—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000577	0.00339	CbGpPWpGaD
Fenoldopam—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000567	0.00333	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000563	0.00331	CbGpPWpGaD
Fenoldopam—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000532	0.00312	CbGpPWpGaD
Fenoldopam—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000513	0.00301	CbGpPWpGaD
Fenoldopam—ADRA2A—brain—Gilles de la Tourette syndrome	0.000488	0.0164	CbGeAlD
Fenoldopam—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000477	0.0028	CbGpPWpGaD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000385	0.00226	CbGpPWpGaD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000373	0.00219	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000368	0.00216	CbGpPWpGaD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000348	0.00204	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00033	0.00193	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00032	0.00188	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000312	0.00183	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000303	0.00178	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000298	0.00175	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000282	0.00166	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000256	0.0015	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000252	0.00148	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000251	0.00147	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000248	0.00146	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000245	0.00144	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000245	0.00144	CbGpPWpGaD
Fenoldopam—DRD5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000244	0.00143	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000244	0.00143	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000238	0.0014	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000236	0.00138	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000231	0.00136	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000229	0.00134	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000229	0.00134	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000228	0.00134	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000228	0.00134	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000227	0.00133	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000222	0.00131	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000222	0.0013	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000221	0.0013	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000219	0.00128	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000216	0.00127	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000213	0.00125	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000213	0.00125	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00021	0.00123	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000209	0.00123	CbGpPWpGaD
Fenoldopam—DRD5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000209	0.00122	CbGpPWpGaD
Fenoldopam—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000208	0.00122	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000207	0.00122	CbGpPWpGaD
Fenoldopam—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000207	0.00121	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000206	0.00121	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000206	0.00121	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000203	0.00119	CbGpPWpGaD
Fenoldopam—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000202	0.00118	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000198	0.00116	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000195	0.00115	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000195	0.00114	CbGpPWpGaD
Fenoldopam—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000193	0.00113	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000192	0.00113	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000189	0.00111	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000189	0.00111	CbGpPWpGaD
Fenoldopam—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000187	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000186	0.00109	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000186	0.00109	CbGpPWpGaD
Fenoldopam—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000185	0.00108	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000182	0.00107	CbGpPWpGaD
Fenoldopam—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000181	0.00106	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00018	0.00106	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000179	0.00105	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000177	0.00104	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000176	0.00104	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000174	0.00102	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000173	0.00101	CbGpPWpGaD
Fenoldopam—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000171	0.00101	CbGpPWpGaD
Fenoldopam—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000168	0.000988	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000168	0.000987	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000168	0.000984	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000167	0.000978	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000165	0.00097	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000165	0.000967	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000165	0.000965	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000162	0.000952	CbGpPWpGaD
Fenoldopam—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000162	0.00095	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000162	0.00095	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00016	0.000942	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00016	0.000937	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00016	0.000937	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000159	0.000935	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000159	0.000933	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000156	0.000917	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000155	0.000907	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000153	0.0009	CbGpPWpGaD
Fenoldopam—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000152	0.000894	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000151	0.000885	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000149	0.000873	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000149	0.000872	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000148	0.000868	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000144	0.000846	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000144	0.000846	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000144	0.000845	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000144	0.000843	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000142	0.000832	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000139	0.000814	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000139	0.000814	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000138	0.000808	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000137	0.000803	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000137	0.000801	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000136	0.0008	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000135	0.00079	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000135	0.00079	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000134	0.000788	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000134	0.000785	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	0.000133	0.000781	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000133	0.000778	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000133	0.000778	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000129	0.000756	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000128	0.000753	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000126	0.000739	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000125	0.000736	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000125	0.000734	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000124	0.000725	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000123	0.000725	CbGpPWpGaD
Fenoldopam—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000122	0.000717	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000122	0.000717	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000121	0.000712	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000118	0.000691	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000118	0.000691	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000116	0.000683	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000115	0.000677	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000114	0.000667	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000113	0.000661	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00011	0.000644	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000109	0.000642	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000109	0.000642	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000108	0.000634	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000106	0.00062	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000105	0.000614	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000104	0.000612	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000102	0.000598	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000101	0.000592	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.42e-05	0.000553	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.41e-05	0.000552	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.37e-05	0.00055	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.3e-05	0.000546	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.15e-05	0.000537	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	9.03e-05	0.00053	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	8.98e-05	0.000527	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.79e-05	0.000516	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.65e-05	0.000508	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.56e-05	0.000502	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.52e-05	0.0005	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.44e-05	0.000495	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.41e-05	0.000493	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.39e-05	0.000493	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.31e-05	0.000487	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8.2e-05	0.000481	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	8.16e-05	0.000479	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.15e-05	0.000478	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.97e-05	0.000468	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.84e-05	0.00046	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.74e-05	0.000454	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.72e-05	0.000453	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.68e-05	0.000451	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.64e-05	0.000448	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.62e-05	0.000447	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.61e-05	0.000447	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.61e-05	0.000446	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.59e-05	0.000445	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.49e-05	0.00044	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.4e-05	0.000434	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	7.39e-05	0.000433	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.14e-05	0.000419	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.12e-05	0.000418	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.11e-05	0.000417	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.09e-05	0.000416	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.01e-05	0.000411	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.98e-05	0.00041	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.91e-05	0.000406	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.91e-05	0.000405	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.89e-05	0.000405	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.88e-05	0.000404	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.85e-05	0.000402	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.8e-05	0.000399	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.65e-05	0.00039	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.46e-05	0.000379	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.44e-05	0.000378	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.37e-05	0.000374	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.34e-05	0.000372	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.27e-05	0.000368	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.22e-05	0.000365	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.2e-05	0.000364	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.18e-05	0.000363	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.04e-05	0.000355	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.97e-05	0.00035	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.89e-05	0.000346	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.78e-05	0.000339	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.76e-05	0.000338	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.63e-05	0.00033	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.61e-05	0.000329	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.42e-05	0.000318	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.35e-05	0.000314	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.32e-05	0.000312	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.23e-05	0.000307	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	5.05e-05	0.000297	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.99e-05	0.000293	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.97e-05	0.000291	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.91e-05	0.000288	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.89e-05	0.000287	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.84e-05	0.000284	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.83e-05	0.000283	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.82e-05	0.000283	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.57e-05	0.000268	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.51e-05	0.000265	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.51e-05	0.000265	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.51e-05	0.000264	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.5e-05	0.000264	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.44e-05	0.00026	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.37e-05	0.000257	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.34e-05	0.000255	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.000247	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.14e-05	0.000243	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.09e-05	0.00024	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.08e-05	0.00024	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.07e-05	0.000239	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.03e-05	0.000237	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.02e-05	0.000236	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.000231	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.82e-05	0.000224	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.8e-05	0.000223	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.74e-05	0.00022	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.7e-05	0.000217	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.68e-05	0.000216	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.66e-05	0.000215	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.57e-05	0.000209	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.42e-05	0.0002	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.33e-05	0.000195	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.32e-05	0.000195	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.2e-05	0.000188	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.16e-05	0.000185	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.09e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.85e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.66e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.62e-05	0.000154	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.42e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.16e-05	0.000127	CbGpPWpGaD
